Skip to main content

Branded

  • Walgreens tracks biggest weekly flu gains in Kentucky, Deleware and South Dakota
    DEERFIELD, Ill. - The Walgreens Flu Index on Thursday indicated that most of the nation is contending with relatively high levels of flu incidence for the week of March 13, with Kentucky, Mississippi and Tennessee topping the charts in states with flu activity. Among states, the biggest flu incidence gainers for the week were Kentucky, Deleware and South Dakota. 
     
    The top 10 markets with flu activity for the week of March 13 were: 
     
    1. El Paso, Texas (Las Cruces, N.M.);

  • Senate passes Ensuring Patient Access and Effective Drug Enforcement Act
    WASHINGTON — The Senate this week unanimously passed the Ensuring Patient Access and Effective Drug Enforcement Act to help ensure that prescription drugs land in the hands of patients and not those who would abuse them.  
     

  • APhA’s House of Delegates adopts new labeling, measuring policy for oral liquid meds
     
    WASHINGTON — The American Pharmacists Association announced Thursday that its House of Delegates had voted to adopt a new policy concerning labeling and measuring of oral liquid medications at the APhA Annual Meeting in Baltimore, Md. 
     

  • Walgreens and UnitedHealth Group's OptumRx partner on 90-day prescription service
    DEERFIELD, Ill. – UnitedHealth Group and Walgreens on Thursday announced the integration of a new pharmacy solution that will enable eligible OptumRx members to fill 90-day prescriptions at home delivery copay levels at any of Walgreens nearly 8,200 pharmacies nationwide or through OptumRx home delivery. 
     
    OptumRx is UnitedHealth Group’s free-standing pharmacy care services business, managing more than one billion prescriptions annually.  
     

  • CDC’s opioid prescribing guideline earns APhA support
    ATLANTA — The Centers for Disease Control and prevention recently released its 2016 opioid prescribing guidelines, aimed at prescribers who recommend opioids for chronic pain outside of cancer treatment, end-of-life care and palliative care, and recommend collaborations with other healthcare professionals, including pharmacists. 
     

  • Allergan announces Vraylar’s availability
    DUBLIN — Allergan on Wednesday announced the availability of its Vraylar (cariprazine) in the United States. The drug is a once-daily atypical antipsychotic indicated to treat acute manic or mixed bipolar I disorder episodes and schizophrenia in adults. 
     
    The drug will be available in 30-count bottles of 1.5-, 3-, 4.5- and 6-mg dosage strengths, as well as a seven-count blister pack containing one 1.5-mg tablet and six 3-mg tablets. 
     

  • Bloomberg: Flu season shows no signs of slowing down

  • Express Scripts: Drug spend grew 5.8% in 2015
    ST. LOUIS — Express Scripts announced this week that it had slowed prescription drug spending growth to 5.3% in 2015, which it attributes to the adoption by clients of the company’s cost-saving solutions and specialized pharmacy care. Specialty spending rose 17.8% in 2015.
     
X
This ad will auto-close in 10 seconds